TME Pharma N.V. (EPA:ALTME)
France · Delayed Price · Currency is EUR 0.1082
+0.0018 (1.69%)
Nov 12, 2026, 10:53 AM CET
TME Pharma Market Cap
TME Pharma has a market cap or net worth of €10.18 million as of November 11, 2026. It is the 40,726th most valuable company in the world and the 524th biggest in France. Its market cap has increased by 37.14% in one year.
Market Cap
10.18M
Enterprise Value
11.48M
Revenue
-27.00K
Global Rank
Country Rank
#524 France
PE Ratio
n/a
ChartMarket Cap Chart
Since September 30, 2016, TME Pharma's market cap has decreased from 43.13M to 10.18M, a decrease of -76.39%. That is a compound annual growth rate of -13.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2026 | 10.18M | 65.95% |
| Dec 31, 2025 | 6.13M | -13.10% |
| Dec 31, 2024 | 7.06M | 478.85% |
| Dec 29, 2023 | 1.22M | -26.24% |
| Dec 30, 2022 | 1.65M | -90.52% |
| Dec 31, 2021 | 17.44M | -28.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MaaT Pharma | 20.16M |
| GenSight Biologics | 18.18M |
| genOway Société anonyme | 17.52M |
| Biophytis | 13.69M |
| Aelis Farma | 11.83M |
| Advicenne | 9.70M |
| Poxel | 8.36M |
| Aton | 5.47M |